Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,065 public trials 1,848 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

NCT06155279

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Humanitas Gavazzeni Bergamo, Italia/Bergamo, Italy
  • IFO - Istituto Tumori Regina Elena, Roma Roma, Italia/Roma, Italy
  • Istituto Clinico Humanitas Rozzano, Milano, Italy
  • Centro di Riferimento Oncologico (CRO) IRCCS Aviano, Pordenone, Italy
View Trial Details
Active, not recruiting

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

NCT05651022

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +31 more
Locations
  • University of Southern California- Norris Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, not recruiting

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

NCT02715284

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
View all 105 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

NCT05353257

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-Stage Small Cell Lung Cancer, +8 more
Locations
  • OPN-Glendale Arcadia, California, United States
  • OPN-Los Alamitos Los Alamitos, California, United States
  • Southern California Permanente Group Los Angeles, California, United States
  • Emad Ibrahim, MD, Inc Redlands, California, United States
View all 129 locations
View Trial Details
Active, not recruiting

Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

NCT05074810

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Rocky Mountain Cancer Center, LLP Boulder, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center, MedStar Georgetown Cancer Institute, Washington D.C., District of Columbia, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
View all 35 locations
View Trial Details
Active, not recruiting

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

NCT02988960

Conditions
Advanced Solid Tumors Cancer, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • The Angeles Clinic and Researc /ID# 156324 Los Angeles, California, United States
  • The University of Chicago Medical Center /ID# 155264 Chicago, Illinois, United States
  • Massachusetts General Hospital /ID# 155267 Boston, Massachusetts, United States
  • Carolina BioOncology Institute /ID# 155265 Huntersville, North Carolina, United States
View all 22 locations
View Trial Details
Active, not recruiting

Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC

NCT04919811

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • The Oncology Institute of Hope and Innovation Glendale, California, United States
  • Moores Cancer Center at UC San Diego La Jolla, California, United States
  • Keck Medicine of University of Southern California Los Angeles, California, United States
View all 77 locations
View Trial Details
Active, not recruiting

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

NCT01025089

Conditions
Clinical Masaoka Stage II to IVA, Hemic and Lymphatic Diseases, Lymphatic Diseases, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
View Trial Details

Related conditions